KOE:214450
PharmaResearch Co., Ltd. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:28 UTC
Last close
n/aKRW
Market data
14.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
22.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
30.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
28.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.31Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.5%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales2.89x
Its own average over 10 years, 185.30B.
- Profit3.23x
Its own average over 10 years, 51.17B.
- Free cash flow4.06x
Its own average over 10 years, 37.83B.
- Debt3.65x
Its own average over 8 years, 58.53B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 4.06 times.
Sales is 2.89 times its own 10-year average; Profit is 3.23 times its own 10-year average; Free cash flow is 4.06 times its own 10-year average; Debt is 3.65 times its own 8-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average2.89
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 10-year average3.23
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 10-year average4.06
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 8-year average3.65
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW